Medchem International India Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 01-01-2025
- Paid Up Capital ₹ 1.28 Cr
as on 01-01-2025
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2020)
- Profit -61.81%
(FY 2020)
- Ebitda -100.00%
(FY 2020)
- Net Worth -36.83%
(FY 2020)
- Total Assets 43709.07%
(FY 2020)
About Medchem International India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.28 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srinivas Bejgam, Ramesh Bejgam, Abhinay Bejgam, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304TG2018PTC127717
- Company No.
127717
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medchem International India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinay Bejgam  | Director | 09-Apr-2021 | Current |
| Srinivas Bejgam | Director | 18-Oct-2018 | Current |
| Ramesh Bejgam | Director | 18-Oct-2018 | Current |
| Aravind Bejgam | Director | 09-Apr-2021 | Current |
Financial Performance of Medchem International India.
Medchem International India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 61.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 36.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medchem International India?
In 2020, Medchem International India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vasu Organics Private LimitedActive 10 years 10 monthsSrinivas Bejgam, Ramesh Bejgam and 2 more are mutual person
Venkatasai Agencies Drugs Private LimitedActive 2 years 10 monthsSrinivas Bejgam is a mutual person
- Vasu Vaccines And Speciality Drugs Hyd Private LimitedActive 2 years 9 months
Srinivas Bejgam and Abhinay Bejgam are mutual person
- Vasu Agencies Drugs Private LimitedActive 2 years 9 months
Ramesh Bejgam and Aravind Bejgam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medchem International India?
Unlock and access historical data on people associated with Medchem International India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medchem International India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medchem International India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
